it is a market convention repeated until it acquired the appearance of a standard
The history of this compound begins in the 1970s, when Loren Pickart isolated from human plasma the factor responsible for the different behavior of liver tissue in culture and determined that it was the copper-binding tripeptide GHK
Compounds affected include BPC-157, TB-500, MOTS-C, GHK-Cu, and Semax each with distinct clinical profiles and dedicated user bases
References Boachie, J., Adaikalakoteswari, A., Samavat, J., & Saravanan, P
The sixth cluster (light blue dots) focuses on NAFLD, insulin resistance, and novel dietary strategies, with a total of 9 keywords including: obesity, non-alcoholic fatty liver disease, metabolic associated steatotic liver disease, insulin resistance, very low-calorie ketogenic diet, etc
Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, Drexler H